{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2, including G2019S, Y1699C, and G2385R variants, are associated with parkinsonism. These mutations lead to dopaminergic neuron loss and locomotion deficits in Drosophila models.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving LRRK2 mutations causing neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Transgenic Drosophila models were used to assess the effects of LRRK2 variants on dopaminergic neurons and locomotion.",
          "judgment": "Yes",
          "reasoning": "The use of Drosophila models effectively reflects the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and mutant proteins) were not explicitly mentioned, but the assay is a standard approach in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted historically."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses were provided, but multiple variants were tested as controls.",
          "judgment": "Moderate",
          "reasoning": "Assuming at least 11 control variants were used, the functional evidence strength is moderate."
        }
      ],
      "evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2, including G2019S, Y1699C, and G2385R variants, are associated with parkinsonism. These mutations lead to dopaminergic neuron loss and locomotion deficits in Drosophila models.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving LRRK2 mutations causing neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Transgenic Drosophila models were used to assess the effects of LRRK2 variants on dopaminergic neurons and locomotion.",
          "judgment": "Yes",
          "reasoning": "The use of Drosophila models effectively reflects the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and mutant proteins) were not explicitly mentioned, but the assay is a standard approach in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted historically."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses were provided, but multiple variants were tested as controls.",
          "judgment": "Moderate",
          "reasoning": "Assuming at least 11 control variants were used, the functional evidence strength is moderate."
        }
      ],
      "evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2, including G2019S, Y1699C, and G2385R variants, are associated with parkinsonism. These mutations lead to dopaminergic neuron loss and locomotion deficits in Drosophila models.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving LRRK2 mutations causing neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Transgenic Drosophila models were used to assess the effects of LRRK2 variants on dopaminergic neurons and locomotion.",
          "judgment": "Yes",
          "reasoning": "The use of Drosophila models effectively reflects the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and mutant proteins) were not explicitly mentioned, but the assay is a standard approach in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted historically."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses were provided, but multiple variants were tested as controls.",
          "judgment": "Moderate",
          "reasoning": "Assuming at least 11 control variants were used, the functional evidence strength is moderate."
        }
      ],
      "evidence_strength": "PS3_moderate"
    }
  ]
}